Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
aldehyde dehydrogenase 6 family member A1 | 0.716 | 0.462 | 7.6E-10 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
alpha 1,4-galactosyltransferase (P blood group) | 0.751 | 0.346 | 7.7E-06 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
alpha-2-glycoprotein 1, zinc-binding | 0.566 | 0.769 | 4.2E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
alpha-L-fucosidase 1 | 0.623 | 0.577 | 2.7E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
aminocarboxymuconate semialdehyde decarboxylase | 0.780 | 0.423 | 1.4E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
anaphase promoting complex subunit 1 | 0.743 | 0.385 | 0.95 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2019 | 2019 | ||||||||
|
angiopoietin 1 | 0.446 | 0.808 | 0.95 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ankyrin 1 | 0.540 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ankyrin repeat and IBR domain containing 1 | 0.861 | 0.077 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ankyrin repeat domain 10 | 0.16 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||||
|
ankyrin repeat domain 11 | 0.556 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ankyrin repeat domain 26 | 0.711 | 0.308 | 3.6E-24 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | ||||||||
|
ankyrin repeat domain 55 | 0.650 | 0.462 | 6.8E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
antizyme inhibitor 1 | 0.716 | 0.462 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
AP2 associated kinase 1 | 0.792 | 0.346 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ArfGAP with dual PH domains 2 | 0.839 | 0.308 | 4.2E-10 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
arginyl aminopeptidase like 1 | 1.000 | 0.077 | 4.1E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
aryl hydrocarbon receptor nuclear translocator like | 0.510 | 0.885 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ASH1 like histone lysine methyltransferase | 0.623 | 0.577 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ASPSCR1 tether for SLC2A4, UBX domain containing | 0.653 | 0.538 | 4.4E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
AT-rich interaction domain 1B | 0.503 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
AT-rich interaction domain 2 | 0.543 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
AT-rich interaction domain 4A | 0.769 | 0.192 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 |